tiprankstipranks
TrivarX Limited’s AI Algorithm Shows Promise in Depression Screening
Company Announcements

TrivarX Limited’s AI Algorithm Shows Promise in Depression Screening

TrivarX Limited (AU:TRI) has released an update.

Don't Miss Our Christmas Offers:

TrivarX Limited has reported promising results from its Phase 2 SAMDE study, showing its AI-driven algorithm, MEB-001, has the potential to significantly improve depression screening. With an 87% sensitivity rate, these findings bolster TrivarX’s ongoing efforts to engage with the FDA for a pivotal trial, a crucial step towards obtaining regulatory approval. The company also enhanced its leadership team with new appointments to support its strategic objectives.

For further insights into AU:TRI stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskTrivarX Director’s Share Acquisition Boosts Stake
TipRanks Australian Auto-Generated NewsdeskTrivarX Limited: Director’s Significant Share Acquisition
TipRanks Australian Auto-Generated NewsdeskTrivarX Limited Updates Director’s Securities Holdings
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App